I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Diabetes has become a major public health problem in China,\[[@ref1]\] affecting an estimated 113.9 million people in addition to the 493.4 million people with prediabetes.\[[@ref2]\] It is often undiagnosed for many years until severe complications occur such as kidney failure, blindness, heart disease, and stroke.\[[@ref3]\] In addition to the health burden, diabetes has imposed a large economic burden on health-care systems worldwide.\[[@ref4]\] Early detection and diagnosis of diabetes to prevent diabetes-associated complications and to reduce the economic burden on medical care is therefore of significant importance.

Routine methods for diabetes screening include fasting plasma glucose (FPG) tests, an oral glucose tolerance test (OGTT), and glycated hemoglobin A1c (HbA1c) measurements. However, FPG alone is not sensitive enough, because isolated hyperglycemia 2 h after glucose loading is common among Chinese patients with diabetes.\[[@ref5][@ref6]\] Moreover, accumulating evidence shows that the efficacy of FPG alone in diabetes screening is questionable.\[[@ref7][@ref8][@ref9][@ref10]\] Although OGTT has been considered the gold standard test for the diagnosis of diabetes, it is not suitable for mass screening due to its complexity, and it is impractical to be conducted for all individuals, especially for those whose FPG is \<7 mmol/L but may have diabetes.\[[@ref11]\] HbA1c is easy to measure, and a previous study has shown that HbA1c could significantly increase the efficacy of using FPG alone in diabetes screening.\[[@ref7]\] However, it is also not practical for mass screening due to the relatively high cost, especially in developing countries. In addition, as a diagnostic test for Chinese people, HbA1c measurement remains controversial because it has not been standardized.

Glucose will appear in the urine when plasma glucose exceeds the renal threshold for glucose resorption. This supports the assumption that urinary glucose (UG) could be an attractive alternative for assessing hyperglycemia. UG is not recommended as a routine screening test for diabetes because its sensitivity is low. However, in previous studies, urine samples were collected 1 h after the main meal of the day, before breakfast, or 1--2 h after a solid morning or evening meal, without uniform specification.\[[@ref12][@ref13][@ref14]\] Moreover, quantitative detection of glycosuria allows more accurate assessment of the average elevation of glucose in the urine compared with the traditional detection with dipsticks.\[[@ref15]\] We consider that UG measured within a specific period of time better reflects the fluctuations in blood glucose and speculate that its lack of sensitivity in diabetes screening could be overcome. Recently, a study by our group confirmed the validity of postprandial UG for diabetes screening in an urban high-risk population, but its utility in the general population is still unclear.\[[@ref10]\] This exploratory study was aimed to examine whether the use of UG would help improve the efficacy of using FPG alone in diabetes screening.

M[ETHODS]{.smallcaps} {#sec1-2}
=====================

Ethical approval {#sec2-1}
----------------

This study was conducted in accordance with the *Declaration of Helsinki* and was approved by the Ethics Review Committee of Jiangsu Provincial Center for Disease Control and Prevention (JSJK2016-B003-03) and Zhongda Hospital, Southeast University. Each participant provided written informed consent.

Subjects {#sec2-2}
--------

This study was initiated on November 12, 2015, and ended on June 28, 2016. We used a multistage, stratified sampling method to select a representative sample of individuals aged between 18 and 65 years in the general population from 6 cities in Jiangsu Province. Individuals without previously diagnosed diabetes were invited to take part in this study. Exclusion criteria were diabetes, pregnancy, a severe psychiatric disturbance, or an unstable health condition. A total of 8119 residents were invited and 7689 participated in this survey. The overall response rate was 94.7%. There were 7485 participants included in the final analysis after the exclusion of 204 participants whose data on HbA1c or UG were missing.

Data collection {#sec2-3}
---------------

A structured questionnaire was used to obtain the information on age, sex, education, lifestyle, family history of chronic disease, and health status. Weight, height, and blood pressure (BP) were measured according to standardized protocols. Body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared.

Participants were first asked to urinate and empty their bladder completely before an OGTT and were restricted from drinking water throughout the whole test. FPG, HbA1c, and 2-h plasma glucose (2h-PG) were measured. All the urine samples were collected over a 2-h period after oral glucose loading for quantitative measurement of UG. FPG and 2h-PG were measured by the glucose oxidase method using an automated chemistry analyzer (Synchron LX-20, Beckman Coulter Inc., California, USA). HbA1c was measured using high-performance liquid chromatography (HPLC, D-10, Bio-Rad Inc., California, USA). Urine glucose concentrations were determined with a quantitative urine meter (UG-201-H, Tanita Corporation, Tokyo, Japan).

Definitions {#sec2-4}
-----------

Diabetes was diagnosed as FPG ≥7.0 mmol/L and/or 2h-PG ≥11.1 mmol/L and/or HbA1c ≥6.5% on the basis of the 2012 American Diabetes Association diagnostic criteria. Prediabetes was defined as FPG ≥5.6 mmol/L and ≤6.9 mmol/L, 2h-PG ≥7.8 mmol/L and \<11.0 mmol/L, or 5.7%≤ HbA1c ≤6.4%.

Statistical analysis {#sec2-5}
--------------------

Continuous variables are presented as the means (95% confidence intervals), and categorical variables are presented as percentages. Student\'s *t*-test and Kappa test were used to compare the characteristics of participants in different groups for continuous variables, and Chi-square tests were used to compare categorical variables. Partial correlation analyses were used to evaluate the associations between UG and other glycemic variables, including FPG, 2h-PG, and HbA1c, after adjustment for age. The receiver operating characteristic (ROC) curves were constructed, and the area under the ROC curve (AUC) was used to evaluate the performance of using UG to detect 2h-PG ≥7.8 mmol/L and 2h-PG ≥11.1 mmol/L. The optimal cutoff points of UG were determined using the maximum of Youden\'s index. A value of *P* \< 0.05 was considered statistically significant. All statistical analyses were conducted using SPSS 22.0 (SPSS Inc., Chicago, IL, USA).

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

General characteristics of study participants {#sec2-6}
---------------------------------------------

According to the predefined criteria, 597 (8.0%) individuals were newly diagnosed with diabetes mellitus, 3645 (48.7%) had prediabetes, and 3243 (43.3%) had normal glucose tolerance. The general characteristics of the study population are presented in [Table 1](#T1){ref-type="table"}. Among them, 3298 (44.1%) were males and 4187 (55.9%) were females. BP, FPG, cholesterol, triglycerides, HDL-C, LDL-C, BMI, and UG were significantly higher in males than those in females. No significant differences in age, 2h-PG, and HbA1c were observed between the two groups.

###### 

Characteristics of study participants according to gender

  Characteristics           Male (*n* = 3298)      Female (*n* = 4187)    Statistics   *P*
  ------------------------- ---------------------- ---------------------- ------------ ---------
  Age (years)               43.6 (43.2--44.1)      44.0 (43.7--44.4)      −1.512\*     0.131
  HR (beats/min)            75.9 (75.5--76.3)      78.9 (78.5--79.4)      −9.894\*     \<0.001
  Blood pressure (mmHg)                                                                
   Systolic                 131.2 (130.6--131.8)   126.0 (125.4--126.6)   11.904\*     \<0.001
   Diastolic                82.0 (81.6--82.4)      77.0 (76.5--77.5)      14.930\*     \<0.001
  Plasma glucose (mmol/L)                                                              
   FPG                      5.6 (5.5--5.6)         5.4 (5.4--5.4)         8.150\*      \<0.001
   2h-PG                    6.6 (6.5--6.7)         6.6 (6.5--6.7)         0.292\*      0.770
  HbA1c (%)                 5.7 (5.6--5.7)         5.7 (5.6--5.7)         −0.115\*     0.909
  Cholesterol (mmol/L)      4.7 (4.7--4.7)         4.6 (4.6--4.7)         3.269\*      0.001
  Triglycerides (mmol/L)    1.9 (1.8--2.0)         1.4 (1.4--1.4)         −14.179^†^   \<0.001
  HDL-C (mmol/L)            1.3 (1.3--1.3)         1.4 (1.4--1.4)         −14.332\*    \<0.001
  LDL-C (mmol/L)            2.7 (2.6--2.7)         2.6 (2.5--2.6)         4.703\*      \<0.001
  BMI (kg/m^2^)             25.5 (25.3--25.6)      24.9 (24.8--25.0)      5.929\*      \<0.001
  UG (mg)                   299.6 (273.3--325.9)   130.7 (116.4--144.9)   −15.869^†^   \<0.001

Data are means (95% *CI*) as indicated. 1 mmHg = 0.133 kPa. \**t* value; ^†^*Z* value. HR: Heart rate; HbA1c: Glycated hemoglobin; FPG: Fasting plasma glucose; 2h-PG: 2-h plasma glucose; HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol; BMI: Body mass index; UG: Urinary glucose; *CI*: Confidence interval.

Correlation of urinary glucose with glycemic variables {#sec2-7}
------------------------------------------------------

As shown in [Figure 1](#F1){ref-type="fig"}, UG was significantly correlated with FPG (*r* = 0.576, *P* \< 0.001), 2h-PG (*r* = 0.580, *P* \< 0.001), and HbA1c (*r* = 0.536, *P* \< 0.001) in males after adjustment for age. Similar correlations were observed in females. In addition, the correlation between 2h-PG and UG was slightly stronger than the correlation between FPG and UG.

![Correlations between UG and glycemic variables including FPG, 2h-PG, and HbA1c after adjustment for age. UG was significantly correlated with FPG, 2h-PG, and HbA1c in males (*r* = 0.576, 0.580, and 0.536, respectively, all *P* \< 0.001; a-c, *n* = 3298). Significant positive correlations were also observed in females (*r* = 0.519, 0.550, and 0.506, respectively, all *P* \< 0.001; d-f, *n* = 4187). UG: Urinary glucose; FPG: Fasting plasma glucose; 2h-PG: 2-h plasma glucose; HbA1c: Glycated hemoglobin A1c.](CMJ-131-1652-g001){#F1}

Performance of urinary glucose in the prediction of 2-h plasma glucose {#sec2-8}
----------------------------------------------------------------------

The ROC curve was employed to evaluate the validity of UG in the prediction of 2h-PG. The AUC for UG was 0.75 for the prediction 2h-PG ≥7.8 mmol/L and 0.90 for the prediction of 2h-PG ≥11.1 mmol/L \[[Figure 2](#F2){ref-type="fig"}\]. Furthermore, UG exhibited a sensitivity of 52.3% and a specificity of 87.8% for the detection of 2h-PG ≥7.8 mmol/L at a corresponding optimal cutoff point of 130 mg and a high sensitivity of 83.5% and a specificity of 87.5% at an optimal cutoff point of 178.5 mg for the prediction 2h-PG ≥11.1 mmol/L \[[Table 2](#T2){ref-type="table"}\].

![ROC curves for UG for identifying 2h-PG ≥7.8 mmol/L (a) and 2h-PG ≥11.1 mmol/L (b). The areas under the ROC curves were 0.75 (95% *CI*: 0.74--0.75) and 0.90 (95% *CI*: 0.89--0.91). ROC: Receiver operating characteristic; UG: Urinary glucose; 2h-PG: 2-h plasma glucose; *CI*: Confidence interval.](CMJ-131-1652-g002){#F2}

###### 

Performance of UG for predicting 2h-PG ≥7.8 mmol/L and ≥11.1 mmol/L

  Parameters           AUC                 Optimal cutoff point (mg)   Sensitivity (%)     Specificity (%)
  -------------------- ------------------- --------------------------- ------------------- -------------------
  2h-PG ≥7.8 mmol/L    0.75 (0.74--0.75)   130.0                       52.3 (49.6--55.0)   87.8 (87.0--88.6)
  2h-PG ≥11.1 mmol/L   0.90 (0.89--0.91)   178.5                       83.5 (79.5--87.1)   87.5 (86.7--88.2)
                                                                                           
  **Parameters**       **PPV (%)**         **NPV (%)**                 **+LR**             **−LR**
                                                                                           
  2h-PG ≥7.8 mmol/L    49.2 (46.6--51.8)   89.1 (88.3--89.9)           4.3 (3.9--4.7)      0.5 (0.5--0.6)
  2h-PG ≥11.1 mmol/L   27.1 (24.6--29.7)   99.0 (98.7--99.2)           6.7 (6.2--7.2)      0.2 (0.2--0.2)

Data are means (95% *CI*). 2h-PG: 2-h plasma glucose; UG: Urinary glucose; AUC: The area under the ROC curves; PPV: Positive predictive value; NPV: Negative predictive value; +LR: Positive likelihood ratio; −LR: Negative likelihood ratio; *CI*: Confidence interval; ROC: Receiver operating characteristic.

Evaluation of fasting plasma glucose combined with urinary glucose in diabetes screening {#sec2-9}
----------------------------------------------------------------------------------------

Using FPG ≥7 mmol/L alone to identify diabetes had an excellent specificity of 100%, but a low sensitivity of only 56.1% (335/597), whereas the combined utilization of FPG and UG showed a significantly higher sensitivity (\[483/597\] 80.9% vs. 56.1%, *χ*^2^ = 85.0, *P* \< 0.001) for detecting diabetes. Further analysis showed that combined utilization of FPG and UG had an absolute sensitivity advantage of 44.2% over FPG alone. Moreover, the sensitivity of using FPG alone (≥5.6 mmol/L) to identify glucose abnormalities was 55.8% (2365/4242), while the sensitivity of combined utilization of FPG and UG was 62.3% (2643/4242), showing an absolute sensitivity advantage of 11.6% over FPG alone.

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

Although FPG has been recommended for routine screening for diabetes, its use is limited because of its low sensitivity.\[[@ref6]\] In support of this, the results of the study showed that using FPG alone does not have sufficient sensitivity to screen for newly diagnosed diabetes (56.1%) in a general population. This also means that nearly half of newly diagnosed diabetes cases could not be detected using FPG alone. In the present study, the sensitivity of UG for the estimation of 2h-PG ≥11.1 mmol/L was 83.5%, suggesting that this test might be useful in detecting individuals with 2h-PG ≥11.1 mmol/L. In addition, the combined utilization of UG and FPG improved the sensitivity to 80.9% for identifying diabetes and to 62.3% for identifying glucose abnormalities. Since FPG is easy to access and UG is noninvasive and available, the combined utilization of UG and FPG is a practical and sufficient test model for diabetes screening, especially in large populations.

Diabetes is a major risk factor for morbidity and mortality, especially in low- and middle-income countries where the diabetes prevalence grows increasingly higher.\[[@ref16]\] Early diagnosis and timely treatments or interventions have been shown to reduce diabetic complications and to prevent or delay the onset of diabetes.\[[@ref9]\] Therefore, screening for diabetes is warranted. Because early-stage type 2 diabetes is often asymptomatic and FPG alone is not sensitive enough for people with only mildly elevated postprandial blood glucose,\[[@ref1][@ref7][@ref17]\] a large proportion of patients with prediabetes or diabetes often have delayed diagnosis until a severe complication occurs. The sensitivity of using FPG alone for detecting diabetes was 56.1%, which is consistent with several other cross-sectional studies.\[[@ref18][@ref19]\] However, the efficacy of FPG for diabetes screening has been questioned. Therefore, some studies have attempted to improve the efficacy of FPG in diabetes screening by introducing new strategies. A study by Wang *et al*.\[[@ref7]\] showed that FPG combined with HbA1c could significantly improve the sensitivity to 88%. In this study, we also investigated the sensitivity of FPG in combination with HbA1c, and a sensitivity of 84.6% was observed (data are not shown). The HbA1c test can be performed at any time of a day and does not require an overnight fast. However, HbA1c may not be suitable for mass screening of large populations because it is relatively expensive. Our previous study demonstrated that the use of serum advanced glycation end products-peptides substantially improved the efficacy of FPG in diabetes screening among high-risk Chinese individuals,\[[@ref19]\] for which a sensitivity of 91.2% was found by combined utilization of advanced glycation end products-peptides and FPG. Nevertheless, the efficacy of advanced glycation end products-peptides in the general population for diabetes screening is unknown.

Based on the findings that UG reflects the prevailing plasma glucose level,\[[@ref20][@ref21]\] studies demonstrated that a postprandial urine test for glucose is an effective approach for diabetes self-monitoring and self-management.\[[@ref22][@ref23]\] A study by our group also showed that quantitative monitoring of urine glucose has comparable efficacy on glycemic control.\[[@ref24]\] However, UG as a screening test for diabetes has been underestimated. Because of poor stability and low sensitivity,\[[@ref12][@ref13]\] traditional urine testing with dipsticks is not recommended for diabetes screening. With the development of a urine glucose meter, quantitative measurement of UG has exhibited a wider measurement range of 0--2 g/L and showed a rapid response within 6 s. Furthermore, it is stable and is not likely to be influenced by various interferents such as ascorbic acid and acetaminophen.\[[@ref15]\] In contrast to traditional urine dipsticks, this quantitative measurement is more sensitive, objective, and accurate. In addition, urine samples were collected without uniform specification in previous studies. The data showed that determining UG over a specific period of time is useful for diabetes screening. Due to its noninvasiveness and availability to pregnant women, UG was also confirmed as the strongest predictor of gestational diabetes.\[[@ref25]\] In addition, our previous study has indicated that UG is a valid tool for detecting both undiagnosed diabetes and prediabetes in high-risk populations.\[[@ref10]\] As a result, UG testing should not be completely given up, especially in low-income regions.

The present study was conducted in a large sample of representative Chinese adults without a history of diagnosed diabetes. The large number of individuals provided our study with high statistical power for data analyses. However, the limitations of this study should be recognized. First, we did not collect multiple urine samples (30 min, 60 min, and 90 min) after the OGTT test. To sufficiently evaluate the use of UG as a screening test and guarantee scientific rigor, participants were required to empty their bladders before the OGTT and were restricted from drinking water during the whole study. Furthermore, all the urine samples were collected over a 2-h period after oral glucose loading. Future studies are required to investigate whether 2-h postprandial UG is the best indicator of diabetes and whether a "spot" urine test after a solid meal is sufficiently effective for diabetes screening. Second, the excretion of urine glucose is mainly mediated by the kidneys, and filtered glucose is reabsorbed by the proximal tubules. This alternative and efficient screening approach might therefore be inappropriate for those with renal function impairment or proximal tubule disorders. Third, it should be mentioned that the present study only involved individuals of Chinese Han ethnicity from the same province. It remains largely unknown whether involving different ethnicities might contribute to differences in sensitivities. More studies are required to confirm our findings.

In conclusion, UG substantially improves the efficacy of using FPG alone in diabetes screening in a general population. Due to its non-invasiveness and effectiveness, the combined measurement of FPG and UG might be a novel approach for mass screening in the general population, and further study is warranted to evaluate whether 2-h postprandial UG is the best indicator of diabetes and whether a "spot" urine test after a solid meal is sufficiently effective for diabetes screening.
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